Antimicrobial Activities of BMS-284756 Compared with Those of Fluoroquinolones and β-Lactams against Gram-Positive Clinical Isolates-Reference-Cited by-同舟云学术

Antimicrobial Activities of BMS-284756 Compared with Those of Fluoroquinolones and β-Lactams against Gram-Positive Clinical Isolates

Published:2002-01 Issue:1 Volume:46 Page:234-238
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Bassetti Matteo¹,Dembry Louise M.¹²,Farrel Patricia A.²,Callan Deborah A.²,Andriole Vincent T.¹

Affiliation:

1. Yale University School of Medicine

2. Yale-New Haven Hospital New Haven, Connecticut

Abstract

ABSTRACT The in vitro antibacterial activity of BMS-284756 was compared to those of ciprofloxacin, gatifloxacin, moxifloxacin, ceftriaxone, imipenem, piperacillin-tazobactam, and amoxicillin-clavulanic acid against 492 gram-positive clinical isolates. BMS-284756 was the most-active agent against Streptococcus pneumoniae , Streptococcus viridans , beta-hemolytic streptococci, methicillin-sensitive and -resistant Staphylococcus aureus , methicillin-sensitive and -resistant coagulase-negative staphylococci, and enterococci.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.46.1.234-238.2002

Reference16 articles.

1. Bauenfiend, A. 1997. Comparison of the antibacterial activities of the quinolones Bay 12–8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. J. Antimicrob. Chemother.40:639–651.

2. Bloundeau, J. M., R. Laskowski, J. Bjarnason, and C. Stewart. 2000. Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms. Int. J. Antimicrob. Agents14:45–50.

3. Rapid Development of Ciprofloxacin Resistance in Methicillin-Susceptible and -Resistant Staphylococcus aureus

4. Brown, D. F., and L. Brown. 1991. Evaluation of the E test, a novel method of quantifying antimicrobial activity. J. Antimicrob. Chemother.27:185–190.

5. Diekema, D. J., R. N. Jones, and K. V. I. Rolston. 1999. Antimicrobial activity of gatifloxacin compared to seven other compounds tested against Gram-positive organisms isolated at 10 cancer-treatment centers. Diagn. Microbiol. Infect. Dis.34:37–43.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alternative Strategies for Proof-of-Principle Studies of Antibacterial Agents;Antimicrobial Agents and Chemotherapy;2014-05-27

2. Activity In Vitro of the Quinolones;Quinolone Antimicrobial Agents;2014-04-08

3. Oral Garenoxacin in the Treatment of Acute Bacterial Maxillary Sinusitis: A Phase II, Multicenter, Noncomparative, Open-Label Study in Adult Patients Undergoing Sinus Aspiration;Clinical Therapeutics;2007-08

4. Penetration of garenoxacin into lung tissues and bone in subjects undergoing lung biopsy or resection;Current Medical Research and Opinion;2007-06-28

5. Piperacillin–tazobactam: a β-lactam/β-lactamase inhibitor combination;Expert Review of Anti-infective Therapy;2007-06